$CTXR News Article - Citius Pharmaceuticals, Inc.
Post# of 47
(Total Views: 193)
Posted On: 12/01/2022 3:15:49 PM
$CTXR News Article - Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Acceptance of Biologics License Application of Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/citi...19646.html
(0)
(0)Citius Pharmaceuticals Inc. (CTXR) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼